Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-030115
Filing Date
2026-03-18
Accepted
2026-03-18 09:39:43
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 11679
  Complete submission text file 0001213900-26-030115.txt   13163
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Issuer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address LEVEL 38, 55 COLLINS STREET MELBOURNE Australia VIC 3000
Business Address
BELL JANE CATHERINE (Reporting) CIK: 0002120692 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37626 | Film No.: 26766289